2026 NPPES data Hematology & Oncology Physician NPI 1487603841 MD
Verify on CMS →

MOLLIE DESHAZO, MD

Hematology & Oncology Physician in BIRMINGHAM, Alabama. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
1K
Medicare Part D claims · 173 beneficiaries · Hematology & Oncology Physician avg: 847
Generic prescribing
67%
generic claims · 33% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$14.8K
61 payments · CMS Open Payments (Sunshine Act)
What the federal data reveals: MOLLIE DESHAZO, MD is a Hematology & Oncology Physician ([object Object]) practicing in BIRMINGHAM, Alabama with a Medicare Part D prescribing footprint of 1K claims across 173 beneficiaries — 33% brand-name prescribing . Industry payments of $14.8K across 61 transactions are disclosed under CMS Open Payments (Sunshine Act).

What stands out: MOLLIE DESHAZO, MD filed 1,256 Medicare Part D claims in 2023 across BIRMINGHAM, Alabama. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

Board certification likely (heuristic — not verified)

MOLLIE DESHAZO, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

MOLLIE DESHAZO, MD at a glance

Quality data not reported

NPI registry status

Active

Issued 05/10/2006

NPI 1487603841

Primary specialty

Hematology & Oncology Physician

Mid-sized

11,215 US NPIs in this specialty

Medicare Part D claims

1,256 48% vs specialty avg

2023 prescription claims

Specialty avg: 847

Specialty distribution in Alabama

How Hematology & Oncology Physician compares to other specialties among Alabama providers

Alabama providers

Hematology & Oncology Physician share within Alabama

1. Hematology & Oncology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Hematology & Oncology Physician share within Alabama

Specialty board-certification context

Estimated specialty board-certified rate — Hematology & Oncology Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Hematology & Oncology Physician ABMS/AOA estimate

Est. board-certified rate (Hematology & Oncology Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Hematology & Oncology Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

MOLLIE DESHAZO, MD is a Hematology & Oncology Physician provider practicing in BIRMINGHAM, Alabama, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: MD. NPI: 1487603841. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

MOLLIE DESHAZO, MD appears in the CMS NPPES registry as a Hematology & Oncology Physician provider holding MD credentials at 619 19TH STREET SOUTH, BIRMINGHAM, AL, 35233, with a listed phone of (205) 934-6600. NPI 1487603841 was issued on 05/10/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what DESHAZO most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 1,256 prescription claims written by this provider, covering 173 Medicare beneficiaries and totaling roughly $3.9 million in drug spend, split 33% brand-name and 67% generic by claim count, with an opioid prescribing rate of 18.1%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Hematology & Oncology Physician is a mid-sized specialty nationwide, with 11,215 enrolled providers across 54 states and an average of 847 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

619 19TH STREET SOUTH
BIRMINGHAM, AL 35233

Provider Details

NPI 1487603841
Specialty Hematology & Oncology Physician
Credentials MD
Gender Female
NPI Issued 05/10/2006

Hospital and facility affiliations

Facilities where MOLLIE DESHAZO, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

UNIVERSITY OF ALABAMA HEALTH SERVICES FOUNDATION, PC
BIRMINGHAM, AL

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for MOLLIE DESHAZO, MD. Source: openpaymentsdata.cms.gov.

Total received

$14.8K

Largest payer

PFIZER INC.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

Brand vs generic prescribing mix · Above average

MOLLIE DESHAZO, MD — brand share 33.0%
Specialty average (est.)

33% brand-name claims vs 67% generic, on 1,256 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

1,256
Total Claims
$3.9M
Total Drug Cost
173
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
1,433
Total Day Supply
39,081
Brand vs Generic
33% brand / 67% generic
Brand Drug Cost
$3.4M
Generic Drug Cost
$450K
Opioid Claims
227 (18.1% rate)
Antibiotic Claims
14

Patient Demographics

Average Patient Age
74.7 years
Avg HCC Risk Score
2.49
Gender Split
10% female / 90% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Orgovyx
Relugolix
196
Hydrocodone-Acetaminophen
Hydrocodone/Acetaminophen
80
Gabapentin
78
Abiraterone Acetate
72
Oxycodone-Acetaminophen
Oxycodone Hcl/Acetaminophen
64
Prednisone
61
Erleada
Apalutamide
60
Nubeqa
Darolutamide
39
Tamsulosin Hcl
38
Ondansetron Odt
Ondansetron
33

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Hematology & Oncology Physician Overview

How MOLLIE DESHAZO, MD fits within the Hematology & Oncology Physician landscape nationally.

11,215
Hematology & Oncology Physician Providers in US
54
States with Hematology & Oncology Physician
847
Avg Claims per Provider

MOLLIE DESHAZO, MD's 1,256 claims are above the specialty average of 847.

Nearby Hematology & Oncology Physician Providers in Alabama

Other clinicians with the same primary specialty enrolled in Alabama, drawn from the same CMS NPPES roster as DESHAZO.

Compare Hematology & Oncology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is MOLLIE DESHAZO, MD's specialty?
MOLLIE DESHAZO, MD specializes in Hematology & Oncology Physician and practices in BIRMINGHAM, Alabama. Credentials: MD.
How much does MOLLIE DESHAZO, MD prescribe under Medicare Part D?
In 2023, MOLLIE DESHAZO, MD wrote 1,256 Medicare Part D claims totaling $3.9M in drug costs for 173 beneficiaries.
Where is MOLLIE DESHAZO, MD located?
MOLLIE DESHAZO, MD is located at 619 19TH STREET SOUTH, BIRMINGHAM, AL, 35233. Phone: (205) 934-6600.
What is MOLLIE DESHAZO, MD's NPI number?
MOLLIE DESHAZO, MD's National Provider Identifier (NPI) is 1487603841, issued on 05/10/2006.
Does MOLLIE DESHAZO, MD prescribe more brand-name or generic drugs?
MOLLIE DESHAZO, MD's prescribing is 33% brand-name and 67% generic drugs by claim count, with $3.4M in brand drug costs.
Does MOLLIE DESHAZO, MD prescribe opioids?
Yes, MOLLIE DESHAZO, MD had 227 opioid claims in 2023 with an opioid prescribing rate of 18.1%.
How many Hematology & Oncology Physician providers are there in the US?
There are 11,215 Hematology & Oncology Physician providers across 54 states in the US. The average Hematology & Oncology Physician provider writes 847 Medicare Part D claims per year.
What drugs does MOLLIE DESHAZO, MD prescribe most often?
Based on 2023 Medicare Part D data, MOLLIE DESHAZO, MD's most frequently prescribed drugs include Orgovyx, Hydrocodone-Acetaminophen, Gabapentin. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does MOLLIE DESHAZO, MD accept Medicare?
MOLLIE DESHAZO, MD appears in CMS Medicare data with 1,256 Part D claims and 173 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify MOLLIE DESHAZO, MD's credentials?
MOLLIE DESHAZO, MD's NPI is 1487603841 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology